Prozkoumejte nejčtenější články a videa na Campus Sanofi
Can remission become the new benchmark in CRSwNP care? In this episode, our expert panel explores the evolving treatment landscape and what "remission" truly means for patients and clinicians. Join us as we look ahead to a future beyond symptom control - where long-term outcomes and deeper disease understanding could transform the way we define treatment success.
ALMA representa un nuevo canal de comunicación que complementa nuestro programa, brindando respuestas inmediatas y contenido relevante en el momento exacto que los pacientes lo requieren.
What links CRSwNP, asthma, and other comorbidities? In this episode, our experts unpack the unified airways concept and why it’s key to understanding Type 2 inflammation and optimizing patient care. Our experts discuss integrated care approaches and what they mean for clinical practice.
Efficacy and safety of switching to iGlarLixi from premixed insulins in people with type 2 diabetes